Having a second autoimmune disease alongside multiple sclerosis (MS) does not accelerate disability progression, according to ...

Ding, C. (2026) The Effect of Integrated Medical and Nursing Care on the Rehabilitation of Disabled Elderly. Journal of Biosciences and Medicines, 14, 376-385. doi: 10.4236/jbm.2026.144027 .

Mapi Pharma’s GA Depot was associated with stable disability scores over time in people with both RMS and PPMS, data show.

Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to teriflunomide in reducing relapses and brain lesions in relapsing multiple ...

BLOG OVERVIEW: OFCCP's Voluntary Self-Identification of Disability Form (CC-305) is set to expire on April 30, 2026. Under the Paperwork Reduction Act, federal agencies must seek OMB approval every ...

Please provide your email address to receive an email when new articles are posted on . Patients wore accelerometers for 24 hours a day for 2 weeks. Disease progression was more likely with decreases ...

Attorney Houston is the longtime judge for Red Bank, but he has not been able to sit for some months due to a medical issue. Attorney Bryan Hoss has been presiding in his place. Mr. Houston cannot ...

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) – Late-breaking Phase III FENtrepid ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Multiple sclerosis is a ...

Lower urinary tract symptoms (LUTS) remain one of the most prevalent and disabling clinical manifestations in multiple sclerosis (MS) patients, often emerging early in the disease course and ...